YouTube is taking immediate action to expand its “medical misinformation” censorship policies, according to a blog post by the popular video platform on Tuesday.
YouTube is streamlining its existing policy to three distinct categories in anticipation of more long-term suppression of medical information authorities disagree with, according to the announcement. A significant portion of YouTube’s announcement focuses on how it will now censor certain cancer-related content.
“Starting today and ramping up in the coming weeks, we will begin removing content that promotes cancer treatments proven to be harmful or ineffective, or content that discourages viewers from seeking professional medical treatment,” the announcement states.
YouTube acknowledges the evolving nature of medical knowledge and information in its announcement.
However, “our goal is to ensure that when it comes to areas of well-studied scientific consensus, YouTube is not a platform for distributing information that could harm people,” its announcement states.
The three categories of “medical misinformation” will be Prevention, Treatment and Denial, according to the announcement. They state that YouTube will remove content that “contradicts health authority guidance.”
Democratic presidential candidate Robert F. Kennedy Jr. is suing YouTube and its parent company, Google, for allegedly violating his free speech, according to a complaint filed Aug. 2. YouTube has removed Kennedy’s videos because of its “vaccine misinformation” policies on multiple occasions, according to the complaint.
Since “YouTube does not allow people to say anything ‘that contradicts local health authorities’ (LHA) or the World Health Organization’s (WHO) medical information about COVID-19,’” this means the government sets the medical censorship guidelines, Kennedy’s lawsuit alleges.
YouTube did not immediately respond to the Daily Caller News Foundation’s request for comment.
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact email@example.com